Identifying The Molecular Mechanisms Of Synergistic And Antagonistic Drug-drug Interactions In Combination Chemotherapies
Funder
National Health and Medical Research Council
Funding Amount
$412,685.00
Summary
Drug combinations in chemotherapy hold promise for more effective treatments and for overcoming drug resistance, but the search for effective combinations is challenging. The combination therapy R-CHOP is often curative for Diffuse Large B-cell Lymphoma (DLBCL). Both cellular drug interactions and evolutionary drug interactions will be quantified in DLBCL cells, to understand the defining features of effective combinations and guide the future rational design of combinations.
System Biology Approaches To Uncovering Non-coding RNAs' Roles In Characterising Cancer Subtypes
Funder
National Health and Medical Research Council
Funding Amount
$318,768.00
Summary
I aim to investigate non-coding RNAs (ncRNAs)’ roles in cancer development, and how they characterise cancer subtypes. The outcomes of the proposed research are twofold: computational methods to stratify tumor subtypes and computational methods to identify groups of ncRNAs acting as drivers for each cancer subtype. The research outcomes will enable prediction of new patients’ cancer subtypes and contribute to the design of efficient treatment therapies.